The 20 Best Renal Cell Carcinoma (RCC) Doctors Near Me in Vienna, 9

Noah Schenkman is a Urologist practicing medicine in Mc Lean, Virginia. Dr. Schenkman is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Perirenal Abscess, Boils, Retroperitoneal Fibrosis, Nephrectomy, and Reconstructive Urology Surgery.

Christopher Rothstein is an Interventional Radiologist practicing medicine in Mc Lean, Virginia. Dr. Rothstein is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Smoldering Multiple Myeloma, Urothelial Cancer, Bladder Cancer, Bone Graft, and Vertebroplasty.

Scott Cassar is a Radiologist practicing medicine in Reston, Virginia. Dr. Cassar is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Diverticular Disease, Pleurisy, and Bronchogenic Cyst.

Nicholas Lailas is a Urologist practicing medicine in Reston, Virginia. Dr. Lailas is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Reconstructive Urology Surgery.

Amit Malhotra is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Malhotra is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Synovial Osteochondromatosis, Tenosynovitis, Rhizarthrosis, and Synovitis.

Paul Cunningham is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Cunningham is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Visceromegaly, Gallbladder Disease, Pleurisy, and Progressive Familial Intrahepatic Cholestasis Type 1.

Brigid Castro is a Radiologist and a Nuclear Medicine provider practicing medicine in Fairfax, Virginia. Dr. Castro is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Collapsed Lung, Pleurisy, Pleural Effusion, and Interstitial Lung Disease.

Nitin Kumar is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Kumar is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Bronchogenic Cyst, Pleurisy, Pleural Effusion, Tracheobronchopathia Osteoplastica, and Gastrostomy.

Wohlscheid Director, Genitourinary Oncology Research Inova Schar Cancer Dr. Jeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as Associate Professor of Medical Education at the University of Virginia. Dr. Aragon-Ching joined Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Program Planning Committee from 2017-2019, served as Track Chair for Urothelial cancers in 2018 and Renal Cell Cancer Track in 2016–2017 and member of the Prostate cancer track. She has chaired different sessions on bladder urothelial and non-urothelial cancers, kidney and prostate cancers. She also served in the ASCO Cancer Education Committee for the annual meeting for the GU non-prostate cancers. She is dedicated to the research and clinical care of patients with genitourinary cancers. Dr. Aragon-Ching completed her internship and residency at the Albert Einstein Medical Center in Philadelphia, PA, where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, MD, where she served as an Associate Investigator on varying trials involved with pharmacogenomics and early drug discovery for genitourinary tumors. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, circulating tumor cells, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. She is a well-published author and investigator of multiple GU trials, including prostate cancer, bladder cancer and kidney cancer trials. She is a well-established educator and serves on the editorial board of various academic journals. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology, Best of ASCO, AUA, EAU, and the ASCO Annual meeting. She has also been previously named a “Top Doctor” by Washingtonian magazine and a “Best Doctor” by the Northern Virginia magazine. Dr. Aragon is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy.

Dr. Angel Yu is a specialty oncology care physician board certified in medical oncology, hematology and internal medicine at Inova Health System. She joined Inova in 2020 and has been in medical practice since 2012. Her area of interest is genitourinary cancers, which include prostate, bladder, kidney, and testicular cancers. She completed her undergraduate education at the University of Pennsylvania with a major in biology, after which she received her doctorate in medicine at the Drexel University College of Medicine. She completed her internal medicine and hematology/oncology training at The George Washington University in Washington, D.C. Prior to joining Inova, Dr. Yu worked as a medical oncologist and hematologist with Novant Health and CaroMont Health, both based in North Carolina. She is excited to return to the D.C. area to focus on providing compassionate, personalized and evidence-based oncology care to patients with genitourinary cancers. Dr. Yu is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Prostate Cancer, and Non-Small Cell Lung Cancer (NSCLC).

Armine Smith, M.D. is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an associate clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine. She is a member of Greenberg Bladder Cancer Institute and the director of Women's Bladder Cancer Program at Sibley Memorial Hospital. She is also a Mary and Armeane Choksi Scholar. Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer. Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association. She has been selected multiple times as a Washington, DC and Virginia top urologist. Dr. Smith specializes in advanced open, minimally invasive and robotic urologic surgery for urologic malignancies, including bladder and upper tract urothelial cancer, kidney cancer, testicular cancer, penile and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidation of risk factors for bladder cancer development, oncologically safe organ preservation in both men and women with bladder and kidney cancer and improving outcomes from bladder cancer treatments. Listen to Dr. Smith’s Cancer Matters podcast episode to learn more about her work. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Smith is board certified in American Board Of Urology.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Paller is board certified in American Board Of Internal Medicine.

Kambiz Tajkarimi is a Urologist practicing medicine in Mclean, Virginia. Dr. Tajkarimi is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His clinical expertise encompasses Enlarged Prostate (BPH), Erectile Dysfunction (ED), Urothelial Cancer, Reconstructive Urology Surgery, and Ureteroscopy.

Christina Brzezniak is a Hematologist and an Oncologist practicing medicine in Reston, Virginia. Dr. Brzezniak is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses HER-2 Positive Breast Cancer, Myeloproliferative Neoplasms (MPN), Lung Cancer, and Paget Disease of the Breast.

Kara Beckner is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Beckner is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 54 other conditions, according to our data. Her clinical expertise encompasses Bronchiectasis, Visceromegaly, Progressive Familial Intrahepatic Cholestasis Type 2, and Progressive Familial Intrahepatic Cholestasis Type 1.

Amandeep Singh is a Radiologist practicing medicine in Fairfax, Virginia. He has been practicing medicine for over 17 years. Dr. Singh is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Visceromegaly, and Gallbladder Disease.

Jong-ho Choi is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Choi is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 69 other conditions, according to our data. His clinical expertise encompasses Bronchiectasis, Pleurisy, Pleural Effusion, Visceromegaly, and Bone Marrow Aspiration.

Franklyn Luke is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Luke is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Visceromegaly, Pleurisy, Pleural Effusion, Bone Marrow Aspiration, and Lymphadenectomy.

Marianne Shih is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Shih is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 46 other conditions, according to our data. Her clinical expertise encompasses Pleurisy, Pleural Effusion, Diverticular Disease, Gallbladder Disease, and Bone Marrow Aspiration.

Ali Tahvildari is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Tahvildari is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Lung Nodules, Gallbladder Disease, and Bone Marrow Aspiration.